Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | XIAP | P98170 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PLEC | Q15149 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL9998254 | 0.97 | TSHR (0.46) | TSHRALDH1A1SMN1; SMN2SOAT1GAA | |
| SCHEMBL3544880 | 0.92 | TSHR (0.43) | TSHRALDH1A1SMN1; SMN2GAARAB9A | |
| SCHEMBL3542619 | 0.92 | TSHR (0.43) | TSHRALDH1A1SMN1; SMN2GAARAB9A | |
| SCHEMBL1471718 | 0.92 | TSHR (0.43) | TSHRALDH1A1SMN1; SMN2GAARAB9A | |
| SCHEMBL3542471 | 0.92 | TSHR (0.43) | TSHRALDH1A1SMN1; SMN2GAARAB9A | |
| SCHEMBL3541324 | 0.92 | TSHR (0.43) | TSHRALDH1A1SMN1; SMN2GAARAB9A | |
| SCHEMBL3542370 | 0.92 | TSHR (0.43) | TSHRALDH1A1SMN1; SMN2GAARAB9A | |
| SCHEMBL3541649 | 0.92 | TSHR (0.43) | TSHRALDH1A1SMN1; SMN2GAARAB9A | |
| SCHEMBL21876976 | 0.92 | TSHR (0.43) | TSHRALDH1A1SMN1; SMN2GAARAB9A | |
| SCHEMBL1469808 | 0.92 | TSHR (0.43) | TSHRALDH1A1SMN1; SMN2GAARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 382 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101728-A1 | FIRE RESISTANT ELECTROLYTE FOR LITHIUM BATTERIES | American Hyperform, Inc. (US) | 2026-05-15 | — | — | WO | claimed |
| US-20260128378-A1 | Fire Resistant Electrolyte for Lithium Batteries | American Hyperform, Inc. (US) | 2026-05-07 | — | — | US | claimed |
| WO-2025111296-A1 | ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES USING THE SAME | II-VI DELAWARE, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| CN-115819280-B | T.bufalin Process for the preparation of esters | 天津均凯农业科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| WO-2024191025-A1 | COSMETIC COMPOSITION COMPRISING CAPSULES OR BEADS | 한국콜마주식회사 | 2024-09-19 | — | — | WO | claimed |
| CN-118507836-B | Electrolyte for secondary lithium metal battery | 深圳欣界能源科技有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-118507836-A | Electrolyte for secondary lithium metal battery | 深圳欣界能源科技有限公司 | 2024-08-16 | — | — | CN | claimed |
| EP-4365175-A1 | NOVEL BENZOPYRAN DERIVATIVE AND USE THEREOF | Spark Biopharma, Inc. (KR) | 2024-05-08 | — | — | EP | claimed |
| US-20240105999-A1 | ORGANIC CARBONATE-BASED HIGH FLASH POINT ELECTROLYTE | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2024-03-28 | — | — | US | claimed |
| CN-117477040-A | Electrolyte and lithium ion battery containing same | 深圳欣视界科技有限公司 | 2024-01-30 | — | — | CN | claimed |
| WO-2010011812-A1 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2010-01-28 | — | — | WO | claimed |
| WO-2009147469-A1 | WATER- BASED COATING COMPOSITION CONTAINING DIALKYL CARBONATES HAVING ETHER FUNCTIONS AS COALESCENT AGENTS AND USE THEROF | LECHLER S.P.A. (IT) | 2009-12-10 | — | — | WO | claimed |
| WO-2009115538-A1 | METHOD FOR PRODUCING URETHANES COMPOSED OF MONO AND DI-FUNCTIONAL AROMATIC AMINES | BASF SE (DE) | 2009-09-24 | — | — | WO | claimed |
| US-20090030195-A1 | 1-(2H)-ISOQUINOLONE DERIVATIVE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2009-01-29 | — | — | US | claimed |
| EP-1854792-A1 | 1-(2H)-ISOQUINOLONE DERIVATIVE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2007-11-14 | — | — | EP | claimed |
| EP-0557167-A1 | Preparation of fluorinated functional compounds | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-08-25 | — | — | EP | claimed |
| US-5191104-A | Complex catalysts | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1993-03-02 | — | — | US | claimed |
| EP-0478074-A2 | Alkoxylation of carboxylated compounds | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) | 1992-04-01 | — | — | EP | claimed |
| EP-0478073-A2 | Processes for the preparation of carboxylated compounds | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) | 1992-04-01 | — | — | EP | claimed |
| US-4238206-A | TERTIARY AMINE OR CARBONATE SOLVENT | COLUMBIA GAS SYSTEM SERVICE CORPORATION (US) | 1980-12-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260128378-A1 | Fire Resistant Electrolyte for Lithium Batteries | FOS, MCU, NCS1 | TSHR 1689/4885ALDH1A1 3843/4885SMN1; SMN2 148/4885 |
| US-20090030195-A1 | 1-(2H)-ISOQUINOLONE DERIVATIVE | NQO1, NR5A1, SRD5A1 | TSHR 4285/4885ALDH1A1 371/4885SMN1; SMN2 2876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.